Conference Call
Available for public viewing via NIH Videocast.
Interagency Pain Research Coordinating Committee
November 2, 2022
Agenda - Draft
10:00 AM: Welcome and Introductions
Dr. Helene Langevin, Director NCCIH, Chair IPRCC
10:35 AM: Minutes June 2022 IPRCC meeting
Dr. Linda Porter, Director Office of Pain Policy and Planning, Designated Federal Official IPRCC
Review and vote on approval of the minutes IPRCC June 7, 2022
10:40 AM: Federal Updates
Dr. Friedhelm Sandbrink Acting National Program Director for Pain Management, VA representative
The VA/DoD Clinical Practice Guideline: Management of Opioid Therapy for Chronic Pain, including the buprenorphine for management of chronic pain recommendation (instead of full agonist opioids).
Dr. Rigoberto Roca Director Center for Drug Evaluation and Research, FDA representative
FDA Efforts to Foster Development of Non-Opioid Medications for Acute Pain Management
Dr. Elisabeth Kato Medical Officer Center for Evidence and Practice Improvement, AHRQ representative
AHRQ Updates
11:30 AM: IPRCC Federal Pain Research Strategy Overview and Progress
Linda Porter, co-chair FPRS
Progress on FPRS Research Priorities and Gaps to Consider
Rebecca Baker, Director NIH HEAL Initiative
Highlighted HEAL Contributions to FPRS
IPRCC Moderators
IPRCC Discussion of Gaps in Remaining Priority Areas
1:15 PM: Break
2:00 PM New Findings from the Pain Research Community: NSAIDS, Benefit or Harm
Dr. Mary Barbe, Professor Lewis Katz School of Medicine, Temple University
Impact of NSAIDS for Chronic Pain in Animal Models
Dr. Luda Diatchenko, Professor Alan Edwards Centre for Research on Pain, McGill University
Increased Risk of Pain Persistence Driven by Anti-inflammatory Treatment for Acute Pain
IPRCC Moderators
IPRCC Discussion of the Potential Impact of these Studies
3:50 PM Topics for the next meeting. Action Items for the Committee
IPRCC Discussion of areas and efforts of interest in pain research
4:30 PM Public Comment
4:35 PM: Adjourn